跳至主要内容
临床试验/ISRCTN16878075
ISRCTN16878075进行中(未招募)未知

Development and implementation of a pilot programme for lung cancer screening in Belarus

.N. Alexandrov National Cancer Centre0 个研究点目标入组 3,000 人开始时间: 2020年9月4日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
3,000

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
Male

入选标准

  • 1. Availability of written informed consent
  • 2. Age from 50 through 70 years
  • 3. Risk-based approach a 5-year lung cancer risk of at least 1.51% (using the Lung Cancer Risk Assessment Tool)
  • 4. No advanced chronic lung diseases
  • 5. No advanced occupational hazard conditions
  • 6. A clinical-functional status allowing the possibility to administer surgical treatment

排除标准

  • 1. Second primaries of synchronous and metachronous cancer of both lungs or a combination of lung cancer with cancer of other organs excluding uterine cervix cancer, non-melanoma skin cancer, and lower lip cancer radically treated at least 3 years ago
  • 2. Previous special treatment for lung cancer
  • 3. Acute tuberculosis
  • 4. Myocardial infarction, stroke in the case history in the course the past 6 months before enrolling in the study
  • Criteria for excluding from the study, based on examination findings:
  • 1. Congestive heart failure, class III or IV according to NYHA (New York Heart Association) classification, unrelated to the neoplastic process
  • 2. Uncontrolled severe hypertension or hypertension with systolic pressure >180 mm Hg and/or diastolic pressure >110 mm Hg, or orthostatic hypotension
  • 3. A positive test for human immunodeficiency virus (HIV), B or C hepatitis, or lues
  • 4. Mental diseases
  • 5. Chronic alcohol addiction
  • 6. Surd mutism
  • Administrative causes for exclusion from the study:
  • 1. Kinship relations between the patient and the Centre’s employers
  • 2. The inability of visits/procedure performance and regular medical check-up
  • 3. Refusal to undergo examination or treatment in the course of the study

研究者

发起方
.N. Alexandrov National Cancer Centre

相似试验